Research News
Share:
BySpondylitis Association of America

When TNF inhibitor medications fail in spondyloarthritis

Biologic medications, such as TNF inhibitors (TNFi) and IL-17 inhibitors (IL-17i), are the current standard in rheumatologic treatment…

Read more
BySpondylitis Association of America

Nonradiographic Axial Spondyloarthritis: The Case for Early TNF-i Interventions in…

In a new video from MedPage Today, esteemed rheumatologist and researcher,…

Read more
BySpondylitis Association of America

A Biosimilar Version of Enbrel Gains FDA Approval

The Food and Drug Administration (FDA) approved the biologic Erelzi, (etanercept-szzs) in late August for conditions including ankylosing spondylitis…

Read more
BySpondylitis Association of America

Genetics of Ankylosing Spondylitis

Ankylosing spondylitis (AS) is considered a complex genetic disease, as more than one gene is involved. We know the importance and weight the HLA-B27 gene…

Read more
BySpondylitis Association of America

Distinguishing Clinical Features in Psoriatic Arthritis

In this new video from MD Magazine, Philip J. Mease, MD –– a respected leader in the field –– outlines…

Read more
BySpondylitis Association of America

Classification of Spondyloarthritis

In this video from MD Magazine, Dr. Philip J. Mease, MD –– a respected leader in the field –– explains the most recent classification guidelines released by…

Read more
1 19 20 21 22 23 24
SAA desktop logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.